TY  - JOUR
AU  - Delgado-Fernández, Marcial
AU  - García-Gemar, Gracia Mar
AU  - Fuentes-López, Ana
AU  - Muñoz-Pérez, Manuel Isidro
AU  - Oyonarte-Gómez, Salvador
AU  - Ruíz-García, Ignacio
AU  - Martín-Carmona, Jessica
AU  - Sanz-Cánovas, Jaime
AU  - Castaño-Carracedo, Manuel Ángel
AU  - Reguera-Iglesias, José María
AU  - Ruíz-Mesa, Juan Diego
PY  - 2021
DO  - 10.1016/j.eimc.2021.01.013
UR  - http://hdl.handle.net/10668/22166
T2  - Enfermedades infecciosas y microbiologia clinica (English ed.)
AB  - Patients lacking humoral response have been suggested to develop a less severe COVID-19, but there are some reports with a prolonged, relapsing or deadly course. From April 2020, there is growing evidence on the benefits of COVID-19 convalescent...
LA  - en
KW  - Convalescent plasma
KW  - Covid-19
KW  - Humoral immunodeficiency
KW  - Inmunodeficiencia humoral
KW  - Obinutuzumab
KW  - Plasma de convalecientes
KW  - Rituximab
TI  - Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature.
TY  - research article
VL  - 40
ER  -